Authors

  • Азизова Р.Б.
  • Абдуқаҳҳоров У.М.

Keywords:

Антифосфолипид синдроми, атеросклероз, кардиоэмболик, инсульт, реабилитация.

References

Andreoli, L., Chighizola, C. B., Banzato, A., Pons-Estel, G. J., Ramire de Jesus, G., & Erkan, D. (2013). Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care & Research, 65(11), 1869-1873.

Asherson, R. A., Cervera, R., de Groot, P. G., Erkan, D., Boffa, M. C., Piette, J. C., ... & Shoenfeld, Y. (2003). Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus, 12(7), 530-534.

Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., ... & Walters, M. R. (2014). Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke, 45(5), 1545-1588.

Cervera, R., Piette, J. C., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., ... & Ingelmo, M. (2002). Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism, 46(4), 1019-1027.

Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., ... & Hughes, G. R. (2009). Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases, 68(9), 1428-1432.

Cervera, R., Rodríguez-Pintó, I., Colafrancesco, S., Conti, F., Valesini, G., Rosário, C., ... & Espinosa, G. (2017). 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmunity Reviews, 16(2), 157-170.

Chighizola, C. B., Ubiali, T., & Meroni, P. L. (2015). Treatment of thrombotic antiphospholipid syndrome: the rationale of current management—an insight into future approaches. Journal of Immunology Research, 2015, 951424.

Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., ... & Kearon, C. (2003). A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. New England Journal of Medicine, 349(12), 1133-1138.

Devreese, K. M., Ortel, T. L., Pengo, V., & de Laat, B. (2020). Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 18(10), 2828-2839.

Erkan, D., Aguiar, C. L., Andrade, D., Cohen, H., Cuadrado, M. J., Danowski, A., ... & Lockshin, M. D. (2014). 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmunity Reviews, 13(6), 685-696.

Erkan, D., Willis, R., Murthy, V. L., Basra, G., Vega, J., Ruiz-Limón, P., ... & Salmon, J. E. (2016). A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Annals of the Rheumatic Diseases, 75(6), 1207-1209.

Garcia, D., Akl, E. A., Carr, R., & Kearon, C. (2012). Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood, 119(9), 2624-2631.

Giannakopoulos, B., & Krilis, S. A. (2013). The pathogenesis of the antiphospholipid syndrome. New England Journal of Medicine, 368(11), 1033-1044.

Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., ... & Salmon, J. E. (2003). Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. Journal of Clinical Investigation, 112(11), 1644-1654.

Hughes, G. R. (1983). Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. British Medical Journal, 287 (6399), 1088-1089.

Kollen, B. J., Kwakkel, G., & Lindeman, E. (2013). Functional recovery after stroke: a review of current developments in stroke rehabilitation research. Reviews in the Neurosciences, 24(3), 227-244.

Köpke, S., Solari, A., Khan, F., Heesen, C., & Giordano, A. (2012). Information provision for people with multiple sclerosis. Cochrane Database of Systematic Reviews, (4), CD008757.

Kozora, E., Hanly, J. G., Lapteva, L., & Filley, C. M. (2008). Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. Arthritis & Rheumatism, 58(11), 3286-3298.

Kozora, E., Laudenslager, M., Lemieux, A., & West, S. G. (2001). Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. Journal of the International Neuropsychological Society, 7(6), 745-754.

Kozora, E., Thompson, L. L., West, S. G., & Kotzin, B. L. (2014). Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis & Rheumatism, 39(12), 2035-2045.

Liestøl, S., Sandset, P. M., Jacobsen, E. M., & Mowinckel, M. C. (2007). Decreased anticoagulant response to dalteparin at term is related to increased thrombin generation. Journal of Thrombosis and Haemostasis, 5(6), 1254-1260.

Miyakis, S., Lockshin, M. D., Atsumi, T., Branch, D. W., Brey, R. L., Cervera, R., ... & Krilis, S. A. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4(2), 295-306.

Nalli, C., Andreoli, L., Casu, C., Tincani, A., & Pregnancy and Antiphospholipid Syndrome Study Group. (2015). Management of recurrent thrombosis in antiphospholipid syndrome. Current Rheumatology Reports, 17(6), 405.

Petri, M., Orbai, A. M., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., ... & Magder, L. S. (2012). Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism, 64(8), 2677-2686.

Pierangeli, S. S., & Harris, E. N. (2008). Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus, 3(4), 247-251.

Rand, J. H., Wu, X. X., Quinn, A. S., Chen, P. P., McCrae, K. R., Bovill, E. G., & Taatjes, D. J. (2003). Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. American Journal of Pathology, 163(3), 1193-1200.

Ruiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010). Antiphospholipid syndrome. The Lancet, 376 (9751), 1498-1509.

Ruiz-Irastorza, G., Hunt, B. J., & Khamashta, M. A. (2007). A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis & Rheumatism, 57(8), 1487-1495.

Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010). Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Annals of the Rheumatic Diseases, 69(1), 20-28.

Ruiz-Irastorza, G., Cuadrado, M. J., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., ... & Khamashta, M. A. (2011). Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus, 20(2), 206-218.

Ruiz-Irastorza, G., Egurbide, M. V., Pijoan, J. I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., ... & Erdozain, J. G. (2018). Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus, 15(9), 577-583.

Sanna, G., Bertolaccini, M. L., Cuadrado, M. J., Laing, H., Mathieu, A., Rovensky, J., ... & Khamashta, M. A. (2003). Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology, 42(2), 200-213.

Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedo-at-Chalumeau, N., ... & Ward, M. M. (2019). EULAR recommendations for the mana-gement of antiphospholipid syndrome in adults. Annals of the Rheumatic Diseases, 78(10), 1296-1304.

Urbanus, R. T., Pennings, M. T., Derksen, R. H., & de Groot, P. G. (2008). Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2'. Journal of Thrombosis and Haemostasis, 6(8), 1405-1412.

Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., ... & Zorowitz, R. D. (2016). Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 47(6), e98-e169.

Заҳира, А. М., Каримов, Ш. И., ва Рашидов, А. Х. (2021). Антифосфолипид синдромининг замонавий диагностика усуллари. Ўзбекистон тиббиёт журнали, 3(2), 45-52.